Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Weight loss drugs may also help reduce alcohol cravings, according to a new study. But you shouldn't use them to help curb ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.